Literature DB >> 27896574

Cognitive function in early HIV infection.

Aanchal Prakash1, Jue Hou2, Lei Liu3, Yi Gao4, Casey Kettering5, Ann B Ragin6.   

Abstract

This study aimed to examine cognitive function in acute/early HIV infection over the subsequent 2 years. Fifty-six HIV+ subjects and 21 seronegative participants of the Chicago Early HIV Infection Study were evaluated using a comprehensive neuropsychological assessment at study enrollment and at 2-year follow-up. Cognitive performance measures were compared in the groups using t tests and mixed-effect models. Patterns of relationship with clinical measures were determined between cognitive function and clinical status markers using Spearman's correlations. At the initial timepoint, the HIV group demonstrated significantly weaker performance on measures of verbal memory, visual memory, psychomotor speed, motor speed, and executive function. A similar pattern was found when cognitive function was examined at follow-up and across both timepoints. The HIV subjects had generally weaker performance on psychomotor speed, executive function, motor speed, visual memory, and verbal memory. The rate of decline in cognitive function across the 2-year follow-up period did not differ between groups. Correlations between clinical status markers and cognitive function at both timepoints showed weaker performance associated with increased disease burden. Neurocognitive difficulty in chronic HIV infection may have very early onset and reflect consequences of initial brain viral invasion and neuroinflammation during the intense, uncontrolled viremia of acute HIV infection. Further characterization of the changes occurring in initial stages of infection and the risk and protective factors for cognitive function could inform new strategies for neuroprotection.

Entities:  

Keywords:  Acute HIV; HIV-associated neurocognitive disorder; NeuroAIDs

Mesh:

Year:  2016        PMID: 27896574     DOI: 10.1007/s13365-016-0498-4

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  45 in total

Review 1.  HIV-1 pathogenesis.

Authors:  Mario Stevenson
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

2.  Abnormalities in resting-state functional connectivity in early human immunodeficiency virus infection.

Authors:  Xue Wang; Paul Foryt; Renee Ochs; Jae-Hoon Chung; Ying Wu; Todd Parrish; Ann B Ragin
Journal:  Brain Connect       Date:  2011

3.  Motor analysis predicts progression in HIV-associated brain disease.

Authors:  G Arendt; H Hefter; F Hilperath; H J von Giesen; G Strohmeyer; H J Freund
Journal:  J Neurol Sci       Date:  1994-05       Impact factor: 3.181

4.  Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis.

Authors:  M Cherner; E Masliah; R J Ellis; T D Marcotte; D J Moore; I Grant; R K Heaton
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

5.  Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

Authors:  Valerio Tozzi; Pietro Balestra; Rita Bellagamba; Angela Corpolongo; Maria Flora Salvatori; Ubaldo Visco-Comandini; Chrysoula Vlassi; Marinella Giulianelli; Simonetta Galgani; Andrea Antinori; Pasquale Narciso
Journal:  J Acquir Immune Defic Syndr       Date:  2007-06-01       Impact factor: 3.731

6.  Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death.

Authors:  N C Sacktor; H Bacellar; D R Hoover; T E Nance-Sproson; O A Selnes; E N Miller; G J Dal Pan; C Kleeberger; A Brown; A Saah; J C McArthur
Journal:  J Neurovirol       Date:  1996-12       Impact factor: 2.643

7.  Neuropsychological test performance before and after HIV-1 seroconversion: the Multicenter AIDS Cohort Study.

Authors:  Quynh T Vo; Christopher Cox; Xiuhong Li; Lisa P Jacobson; Rosemary McKaig; Ned Sacktor; Ola A Selnes; Eileen Martin; James T Becker; Eric N Miller
Journal:  J Neurovirol       Date:  2012-12-11       Impact factor: 2.643

8.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Authors:  Scott Letendre; Jennifer Marquie-Beck; Edmund Capparelli; Brookie Best; David Clifford; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; Susan Morgello; David Simpson; Igor Grant; Ronald J Ellis
Journal:  Arch Neurol       Date:  2008-01

9.  Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.

Authors:  B M Ances; D Sisti; F Vaida; C L Liang; O Leontiev; J E Perthen; R B Buxton; D Benson; D M Smith; S J Little; D D Richman; D J Moore; R J Ellis
Journal:  Neurology       Date:  2009-09-01       Impact factor: 9.910

10.  Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression.

Authors:  Elizabeth Hamlyn; Sarah Fidler; Wolfgang Stöhr; David A Cooper; Giuseppe Tambussi; Mauro Schechter; Jose M Miro; Myra Mcclure; Jonathan Weber; Abdel Babiker; Kholoud Porter
Journal:  AIDS       Date:  2014-03-27       Impact factor: 4.177

View more
  5 in total

1.  Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.

Authors:  Ryan Sanford; Lesley K Fellows; Beau M Ances; D Louis Collins
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

2.  Cognitive and Motor Impairment Severity Related to Signs of Subclinical Wernicke's Encephalopathy in HIV Infection.

Authors:  Anne-Pascale Le Berre; Rosemary Fama; Stephanie A Sassoon; Adolf Pfefferbaum; Edith V Sullivan; Natalie M Zahr
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

3.  Cognitive impairment severity in relation to signs of subclinical Wernicke's encephalopathy in HIV and alcoholism comorbidity.

Authors:  Anne-Pascale Le Berre; Rosemary Fama; Stephanie A Sassoon; Natalie M Zahr; Adolf Pfefferbaum; Edith V Sullivan
Journal:  AIDS       Date:  2020-03-01       Impact factor: 4.632

Review 4.  The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity.

Authors:  Natalie M Zahr
Journal:  Front Aging Neurosci       Date:  2018-03-22       Impact factor: 5.750

Review 5.  Nef-induced CCL2 Expression Contributes to HIV/SIV Brain Invasion and Neuronal Dysfunction.

Authors:  Michael H Lehmann; Jonas M Lehmann; Volker Erfle
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.